Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

• Jae-Sook Ahn,
• Hyeoung-Joon Kim,
• Yeo-Kyeoung Kim,
• Sung-Hoon Jung,
• Deok-Hwan Yang,
• Je-Jung Lee,
• Il-Kwon Lee,
• Nan Young Kim,
• Mark D Minden,
• Chul Won Jung,
• Jun-Ho Jang,
• Hee Je Kim,
• Joon Ho Moon,
• Sang Kyun Sohn,
• Jong-Ho Won,
• Sung-Hyun Kim,
• Namshin Kim,
• Kenichi Yoshida,
• Seishi Ogawa,
• Dennis Dong Hwan Kim

Affiliations

Jae-Sook Ahn

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Hyeoung-Joon Kim

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Yeo-Kyeoung Kim

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Sung-Hoon Jung

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Deok-Hwan Yang

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Je-Jung Lee

Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Il-Kwon Lee

Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Nan Young Kim

Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

Mark D Minden

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Canada

Chul Won Jung

Division of Hematology-Oncology, Samsung Medical Center, Seoul, Republic of Korea

Jun-Ho Jang

Division of Hematology-Oncology, Samsung Medical Center, Seoul, Republic of Korea

Hee Je Kim

Department of Hematology, The Catholic University of Korea, Seoul, Republic of Korea

Joon Ho Moon

Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, Republic of Korea

Sang Kyun Sohn

Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, Republic of Korea

Jong-Ho Won

Department of Hematology-Oncology, Soon Chun Hyang University Hospital, Seoul, Republic of Korea

Sung-Hyun Kim

Department of Hematology-Oncology, Dong-A University College of Medicine, Busan, Republic of Korea

Namshin Kim

Epigenomics Research Center, Genome Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

Kenichi Yoshida

Kyoto University, Japan

Seishi Ogawa

Kyoto University, Japan

Dennis Dong Hwan Kim

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Canada